BioLineRx Ltd.

NASDAQ: BLRX · Real-Time Price · USD
3.75
-0.02 (-0.53%)
At close: Aug 15, 2025, 3:59 PM
3.71
-1.07%
After-hours: Aug 15, 2025, 04:10 PM EDT

BioLineRx Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
28.94M 4.8M n/a n/a
Cost of Revenue
9.26M 3.69M n/a n/a
Gross Profit
19.68M 1.11M n/a n/a
Operating Income
-20.41M -49.69M -29.16M -24.78M
Interest Income
1.82M 2.01M 694K 559K
Pretax Income
-9.22M -60.61M -24.95M -27.05M
Net Income
-9.22M -60.61M -24.95M -27.05M
Selling & General & Admin
28.54M 31.23M 11.53M 5.27M
Research & Development
9.15M 12.52M 17.63M 19.47M
Other Expenses
2.4M 7.05M n/a 42K
Operating Expenses
40.09M 50.8M 29.16M 24.78M
Interest Expense
9.07M 2.17M 2.16M 984K
Selling & Marketing Expenses
10.08M 14.59M 6.46M 1M
Cost & Expenses
49.35M 54.49M 29.16M 24.78M
Income Tax Expense
n/a n/a n/a n/a
Shares Outstanding (Basic)
79.87M 64.22M 51.6M 44.2M
Shares Outstanding (Diluted)
79.87M 64.22M 51.6M 44.2M
EPS (Basic)
-0.12 -0.94 -0.48 -0.61
EPS (Diluted)
-0.12 -0.94 -0.48 -0.61
EBITDA
3.92M -57.09M -28.5M -24.07M
EBIT
-147K -58.47M -29.16M -24.78M
Depreciation & Amortization
4.07M 1.38M 654K 703K